TruScreen Group Ltd. stock analysis
TruScreen Group Ltd. (TRU) Share Price & Analysis
TRU Stock Chart & Stats
- Day’s Range
- AUD 0.01 - AUD 0.01
- 52-Week Range
- AUD 0.01 - AUD 0.02
- Previous Close
- AUD 0.01
- Volume
- N/A
- Average Volume (3M)
- 672.85K
- Market Cap
- AUD 6.82M
- Enterprise Value
- AUD 11.44M
- Total Cash (Recent Filing)
- AUD 1.46M
- Total Debt (Recent Filing)
- AUD 200.69K
- Price to Earnings (P/E)
- ―
- Beta
- 0.36
- Next Earnings
- Nov 26, 2026 (Est.)
- EPS Estimate
- N/A
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
Bulls Say, Bears Say
Bulls Say
Revenue Rebound
FY2026’s 58% revenue rebound indicates renewed commercial traction for the screening offering. If the higher sales level persists, it can expand system usage and consumables activity, although durable benefit depends on converting growth into viable margins.
Low Leverage
Very modest leverage gives TruScreen greater balance-sheet flexibility than a heavily indebted company and limits near-term interest burden. Positive equity relative to debt provides some resilience while management works to improve profitability and cash generation.
Point-of-care Market Positioning
Portable, point-of-care screening addresses access constraints in clinics, hospitals, and screening programs where laboratory testing may be limited. This application focus can support relevance across underserved healthcare settings and differentiate the company’s offering.
Bears Say
Severe Margin Compression
The collapse in gross margin shows that recent revenue growth has not translated into a sustainable earnings model. At roughly 1% gross margin, little revenue remains to cover operating costs, making persistent operating and net losses more likely.
Persistent Cash Burn
Consistently negative operating and free cash flow means the business is consuming cash rather than funding operations internally. The further FY2026 deterioration increases dependence on future financing or improved execution, creating an ongoing constraint on growth.
Capital-base Pressure
A deeply negative return on equity indicates that the company is not currently producing returns from its capital base and that losses are eroding shareholder value. Continued weak profitability could reduce financial flexibility even while leverage remains modest.
TruScreen Group Ltd. News
TRU FAQ
What was TruScreen Group Ltd.’s price range in the past 12 months?
What is TruScreen Group Ltd.’s market cap?
When is TruScreen Group Ltd.’s upcoming earnings report date?
How were TruScreen Group Ltd.’s earnings last quarter?
Is TruScreen Group Ltd. overvalued?
Does TruScreen Group Ltd. pay dividends?
What is TruScreen Group Ltd.’s EPS estimate?
How many shares outstanding does TruScreen Group Ltd. have?
What happened to TruScreen Group Ltd.’s price movement after its last earnings report?
Which hedge fund is a major shareholder of TruScreen Group Ltd.?
What is the TipRanks Smart Score and how is it calculated?
Company Description
TruScreen Group Ltd.
TruScreen Group Limited, alongside its subsidiaries, focuses on the development, manufacturing, and global distribution of advanced systems for cancer detection. Their commercial reach extends across various international territories, including Mexico, China, Russia, Vietnam, Zimbabwe, countries within Eastern Europe, the Middle East/North Africa region, and beyond. A flagship product is the TruScreen cervical cancer screening system, a specialized medical device engineered to provide real-time identification of precancerous and cancerous tissue present on the cervix. Established in 2013, the company, with its primary base of operations in Auckland, New Zealand, officially changed its name from TruScreen Limited to Truscreen Group Limited in August 2020.
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Martin Dillon
- Employees
- 6
- Website
- truscreen.com
- Address
- Equitable House, Auckland, AU, 1010, NZ
TruScreen Group Ltd. (TRU) Earnings & Revenues
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 3 | 5 | 13 |
| Technical Analysis | 2 | 5 | 2 |
| Moving Averages | 1 | 0 | 11 |








